Operating Lease, Right-of-Use Asset of Pharma-Bio Serv, Inc. from 31 Oct 2019 to 31 Jul 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Pharma-Bio Serv, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Oct 2019 to 31 Jul 2025.
  • Pharma-Bio Serv, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Jul 2025 was $72,747, a 70% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Pharma-Bio Serv, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $72,747 -$166,436 -70% 31 Jul 2025 10-Q 15 Sep 2025 2025 Q3
Q1 2025 $115,259 -$163,730 -59% 30 Apr 2025 10-Q 16 Jun 2025 2025 Q2
Q4 2024 $157,211 -$160,948 -51% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q1
Q3 2024 $198,597 -$157,853 -44% 31 Oct 2024 10-Q 15 Sep 2025 2025 Q3
Q2 2024 $239,183 -$154,820 -39% 31 Jul 2024 10-Q 16 Sep 2024 2024 Q3
Q1 2024 $278,989 -$151,846 -35% 30 Apr 2024 10-Q 14 Jun 2024 2024 Q2
Q4 2023 $318,159 -$149,095 -32% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q1
Q3 2023 $356,450 -$146,235 -29% 31 Oct 2023 10-K 29 Jan 2025 2024 FY
Q2 2023 $394,003 -$144,954 -27% 31 Jul 2023 10-Q 14 Sep 2023 2023 Q3
Q1 2023 $430,835 -$141,990 -25% 30 Apr 2023 10-Q 14 Jun 2023 2023 Q2
Q4 2022 $467,254 -$139,167 -23% 31 Jan 2023 10-Q 17 Mar 2023 2023 Q1
Q3 2022 $502,685 -$137,284 -21% 31 Oct 2022 10-K 29 Jan 2024 2023 FY
Q2 2022 $538,957 -$182,607 -25% 31 Jul 2022 10-Q 14 Sep 2022 2022 Q3
Q1 2022 $572,825 -$183,314 -24% 30 Apr 2022 10-Q 14 Jun 2022 2022 Q2
Q4 2021 $606,421 -$184,140 -23% 31 Jan 2022 10-Q 17 Mar 2022 2022 Q1
Q3 2021 $639,969 -$206,745 -24% 31 Oct 2021 10-K 30 Jan 2023 2022 FY
Q2 2021 $721,564 -$119,503 -14% 31 Jul 2021 10-Q 14 Sep 2021 2021 Q3
Q1 2021 $756,139 -$118,701 -14% 30 Apr 2021 10-Q 14 Jun 2021 2021 Q2
Q4 2020 $790,561 -$117,838 -13% 31 Jan 2021 10-Q 17 Mar 2021 2021 Q1
Q3 2020 $846,714 +$846,714 31 Oct 2020 10-K 11 Feb 2022 2021 FY
Q2 2020 $841,067 31 Jul 2020 10-Q 14 Sep 2020 2020 Q3
Q1 2020 $874,840 30 Apr 2020 10-Q 15 Jun 2020 2020 Q2
Q4 2019 $908,399 31 Jan 2020 10-Q 16 Mar 2020 2020 Q1
Q3 2019 $0 31 Oct 2019 10-K 01 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.